|
|
|
Volumn 14, Issue 2, 1996, Pages
|
|
Endothelial function as an end-point in interventional trials: Concepts, methods and current data
|
|
Author keywords
Angiotensin converting enzyme inhibitor; Coronary vasomotion; Endothelin 1; Forearm blood flow; Nitric oxide; Statins
|
|
Indexed keywords
ANTILIPEMIC AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENDOTHELIN 1;
NITRIC OXIDE;
ANGIOCARDIOGRAPHY;
ATHEROSCLEROSIS;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR FUNCTION;
CELL ADHESION;
CELL MIGRATION;
CELL PROLIFERATION;
CONFERENCE PAPER;
CORONARY ARTERY BLOOD FLOW;
CORONARY ARTERY DISEASE;
DOPPLER FLOWMETRY;
DRUG EFFICACY;
DRUG SAFETY;
ENDOTHELIUM CELL;
FORCE;
FOREARM BLOOD FLOW;
HEALTH CARE COST;
HUMAN;
HYPERLIPIDEMIA;
MONOCYTE;
MORBIDITY;
MORTALITY;
PATHOGENESIS;
PERIPHERAL CIRCULATION;
PLETHYSMOGRAPHY;
PRIORITY JOURNAL;
RISK;
RISK FACTOR;
THROMBOCYTE ADHESION;
THROMBOCYTE AGGREGATION INHIBITION;
VASCULAR ENDOTHELIUM;
VASCULAR SMOOTH MUSCLE;
VASODILATATION;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTILIPEMIC AGENTS;
CARDIOVASCULAR DISEASES;
ENDOTHELIN-1;
ENDOTHELIUM, VASCULAR;
NITRIC OXIDE;
|
|
EID: 0029903936
PISSN: 09521178
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (83)
|
|
References (5)
|
